Oligonucleotide and Parylene Surface Coating of Polystyrene and ePTFE for Improved Endothelial Cell Attachment and Hemocompatibility

In vivo self-endothelialization by endothelial cell adhesion on cardiovascular implants is highly desirable. DNA-oligonucleotides are an intriguing coating material with nonimmunogenic characteristics and the feasibility of easy and rapid chemical fabrication. The objective of this study was the cre...

Full description

Saved in:
Bibliographic Details
Main Authors: Martina Schleicher, Jan Hansmann, Bentsian Elkin, Petra J. Kluger, Simone Liebscher, Agnes J. T. Huber, Olaf Fritze, Christine Schille, Michaela Müller, Katja Schenke-Layland, Martina Seifert, Heike Walles, Hans-Peter Wendel, Ulrich A. Stock
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Biomaterials
Online Access:http://dx.doi.org/10.1155/2012/397813
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In vivo self-endothelialization by endothelial cell adhesion on cardiovascular implants is highly desirable. DNA-oligonucleotides are an intriguing coating material with nonimmunogenic characteristics and the feasibility of easy and rapid chemical fabrication. The objective of this study was the creation of cell adhesive DNA-oligonucleotide coatings on vascular implant surfaces. DNA-oligonucleotides immobilized by adsorption on parylene (poly(monoaminomethyl-para-xylene)) coated polystyrene and ePTFE were resistant to high shear stress (9.5 N/m2) and human blood serum for up to 96 h. Adhesion of murine endothelial progenitor cells, HUVECs and endothelial cells from human adult saphenous veins as well as viability over a period of 14 days of HUVECs on oligonucleotide coated samples under dynamic culture conditions was significantly enhanced (P<0.05). Oligonucleotide-coated surfaces revealed low thrombogenicity and excellent hemocompatibility after incubation with human blood. These properties suggest the suitability of immobilization of DNA-oligonucleotides for biofunctionalization of blood vessel substitutes for improved in vivo endothelialization.
ISSN:1687-8787
1687-8795